Tumor-infiltrating lymphocytes, one of the major constituents of TME, refers to the lymphocytes that migrate from the blood to the site of the tumor, including CD8+ T cells, CD4+ T cells, B lymphocytes and NK cells (Yang et al., 2021). Here, CD8A is linked to neoplasm.